FNA (Paragon 28 Inc.) Market Value to Book Value Ratio

Paragon 28 (FNA) - corporate logo

Efficient delivery of sterile kits to clinics minimizes costs and guarantees surgical safety. The price-to-book ratio visualizes the market premium trend, where 8.48 captures the magnitude of this parameter. A wide range of implants and global distribution mitigate risks, while the sector's independence from macroeconomics makes Paragon 28, Inc. (FNA) a reliable defensive asset.

FNA - paragon28.com Market-to-Book Ratio over the range 07/04/2022 - 04/26/2025

FNA (Paragon 28, Inc.): analytical breakdowns and indicator data

- price and consensus price forecast:
Price Chart paragon28.com|FNA - Analyst Median Target
- market capitalization data:
Market Value Paragon 28 Corp|FNA - Full Business Value
- book capitalization data:
Book Value per Share Paragon 28|FNA - Total Stockholders' Equity|Market Capitalization to Book Value Ratio paragon28.com|FNA - Cumulative Company Assets
- debt and liquidity data:
Total Debt to Capital Paragon 28, Inc.|FNA - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital paragon28.com|FNA - Company Aggregate Debts|Debt to Book Capitalization Ratio Paragon 28 Corp|FNA - Company Long-Term Debt|Company Short-Term Debts Paragon 28
Fundamental valuation:Paragon 28, Inc.
Manufactured products of Paragon 28, Inc.

This ratio measures the market value premium over net assets, reflecting investor expectations regarding future returns. An increase in value signals a business overvaluation, while a decrease indicates undervalued capital. By analyzing the market capitalization valuation trend relative to the balance sheet, one can observe the current level of 8.48. This premium is driven by the high value of intellectual capital. The innovation potential of Paragon 28, Inc. (FNA) is supported by a staff of highly qualified biomedical specialists and significant R&D investments.

Competitor analysis

Boston Scientific - Market Value to Book Value Ratio|EW (edwards.com) - Market Capitalization to Book Value|Market Value to Book Value Ratio ResMed RMD|Market Capitalization to Net Assets Insulet Corp|Zimmer Biomet Holdings, Inc. - Market Capitalization to Book Value Ratio|Market-to-Book Ratio CooperSurgical (COO)|Align Technology, Inc. - Market Capitalization to Book Value Ratio|Market Cap to Net Assets Ratio globusmedical.com GMED|Market Capitalization to Book Value Ratio TMDX (TransMedics Group)|ATEC - Market Capitalization to Book Value|AORT: Market Capitalization to Book Value Ratio|ENOV (Enovis Inc.) - Market Capitalization to Book Value Ratio|Market Value to Book Value Ratio Integra LifeSciences|Market Value to Book Value Ratio establishmentlabs.com|BBNX (Beta Bionics) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value IRADIMED Corp IRMD|Embecta Inc. (EMBC) - Market Cap to Net Assets Ratio|Market Capitalization to Net Assets Tandem Corp TNDM|AXGN (AxoGen, Inc.) - Market Capitalization to Book Value Ratio|SIBN - Market-to-Book Ratio|Market Capitalization to Book Value Ratio Orthofix|Capitalization to Book Value Ratio Bioventus Inc|KIDS - Market Cap to Net Assets Ratio|Market Value to Book Value TMCI|Market Value to Book Value Ratio SRTA (Strata Critical Medical Inc)|Market Cap to Net Assets Ratio carlsmed.com (CARL)|RXST: Market Capitalization to Book Value Ratio|Market-to-Book Ratio ClearPoint Neuro Inc. CLPT|Stereotaxis Corp (STXS) - Market Capitalization to Book Value Ratio|STIM - Capitalization to Book Value Ratio|Sight Sciences, Inc. - Market Capitalization to Book Value Ratio|orchestrabiomed.com (OBIO) - Market Capitalization to Book Value|Market Capitalization to Book Value Ratio ANIK|Market Cap to Net Assets Ratio InspireMD Inc|Market Capitalization to Book Value Ratio ZJYL|Market Capitalization to Book Value Ratio VANI (vivani.com)|Market Value to Book Value Ratio Xtant Medical XTNT|NMTC - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio Modular Med (MODD)|MYO - Market Value to Book Value|Market Capitalization to Book Value Ratio COCH|VVOS (Vivos Therapeutics Inc) - Market-to-Book Ratio|enVVeno Medical - Market Value to Book Value Ratio|Market Value to Equity Ratio SINTX Technologies (SINT)|Market Cap to Net Assets Ratio TNON|Market Capitalization to Book Value Ratio ReWalk Robotics (LFWD)|Market Capitalization to Book Value Ratio AMIX|INVO Fertility Corp - Market Capitalization to Book Value|Market Value to Book Value Ratio Bone Biologics|AXNX: Market Capitalization to Net Assets|BIOL (BIOLASE) - Market Value to Book Value Ratio|Dynatronics (DYNT) - Market Cap to Net Assets Ratio|Market Capitalization to Book Value Ratio INVO (INVO Bioscience Inc.)